AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA BioTech SPRC SciSparc Subsidiary NeuroThera Labs Completes Acquisition Of CliniQuantum; Stock Up June 04, 2026 — 10:23 am EDT Written by RTTNews.com for RTTNews -> (RTTNews) - SciSparc Ltd. (SPRC), a clinical-stage biopharmaceutical company focused on central nervous system disorders, announced that its subsidiary NeuroThera Labs Inc. (NTLX) has completed the acquisition of a majority stake in CliniQuantum Ltd. Under the purchase agreement, NeuroThera acquired approximately 54% of CliniQuantum's issued and outstanding shares in exchange for common shares valued at about CAD$9.46 million. In addition, CliniQuantum's selling shareholders may be eligible for earn-out payments of up to $2.5 million, contingent on milestones such as patent filings and fundraising achievements. CliniQuantum is a private Israeli technology company developing a platform that applies quantum simulation and Monte Carlo methods to clinical trial data analysis. The goal is to improve trial precision by identifying patient subgroups that respond more effectively to investigational therapies. The company's key asset is a license agreement with Quantum X Labs Ltd., granting exclusive worldwide rights to certain patents and know-how in the field of quantum simulation for clinical trials. This includes a U.S. provisional patent application covering advanced quantum sampling methods. The acquisition strengthens NeuroThera's technological capabilities and positions SciSparc to integrate quantum-based analytics into its drug development pipeline. The transaction is expected to accelerate clinical trial precision and broaden therapeutic applications in central nervous system disorders. The company recently implemented a 1-for-9 reverse stock split on March 2, 2026. SPRC is currently trading at $12.50, up 32.14%. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Tags BioTech RTTNews Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges. More articles by this source -> Stocks mentioned SPRC More Related Articles This data feed is not available at this time. Data is currently not available • Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.